Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18 USD | +1.78% | -9.97% | +64.58% |
10/05 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
09/05 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |